One of the outstanding issues of modern medicine is to combat pain effectively. Jose Vicente Torres Pérez, a Spanish researcher who works at Imperial College in London, set out to curb the suffering of people with serious burns.
Torres found that blocking a new genetic marker can reduce the neural activation caused by painful stimuli.
As Torres, the only Spanish researcher participating in the study published today in the journal ‘Scientific Reports’, explains to SINC: “The cell activation markers most used today are pERK1/2 and c-Fos, but both have their limitations.”
The development and persistence of pain depends on plastic changes to the neurons that process information on noxious stimuli, which are those of the dorsal spinal cord.
These plastic changes are largely regulated by epigenetic mechanisms, i.e. chemical changes that alter the expression of the genes, but not their sequence, such as post-translational modifications of histones.
“Seeking new pain markers continues to be very important in the field of nociception, which analyses the subjective experience of pain, and a need that has not yet been met,” adds Torres Pérez.
New pain relief therapy
Technically, the team in which the Spanish expert works has demonstrated in mice that a population of superficial neurons in the spinal cord controls an epigenetic marker known as pS10H3.
“We observed the effect after using various animal pain models: inducing burns, applying capsaicin or electrical nerve stimulation,” explains Torres Pérez. Therefore, the authors believe that, if this activation is blocked, they will achieve a new pain relief therapy.
For the Spanish researcher, “pS10H3 is a new marker of pain processing in neurons on the spinal cord, and the changes caused by it are fundamental to normal pain development, which opens up new therapeutic possibilities.”
Application to burn victims
Recent advances have significantly increased the survival rates of burn victims, but little has been achieved to alleviate the pain they suffer.
According to the authors, advances that help to decipher the molecular mechanisms produced in neurons that are key to processing pain – such as the discovery of this alteration – will help to find new therapeutic strategies.
“We propose that blocking this epigenetic modification could be a new strategy to try to reduce or completely eliminate the pain after these processes,” Torres Pérez concludes.
Receive an email update when we add a new EPIGENETICS article.
The Latest on: Epigenetics
via Google News
The Latest on: Epigenetics
- Resverlogix to Present at Upcoming Conferenceson October 13, 2021 at 5:00 am
Presentation Highlights will Include First-in-Class Epigenetic Small Molecule Candidate Apabetalone Being Evaluated as Potential Treatment for COVID-19CALGARY, Alberta, Oct. 13, 2021 (GLOBE NEWSWIRE) ...
- Kansas chiropractors spread misinformation about COVID vaccines, without consequenceon October 12, 2021 at 2:29 pm
Chiropractors have become major purveyors of misinformation about COVID treatments and have given hundreds of thousands of dollars to anti-vaccine events.
- Study Probes Role of Epigenetics in Precision Medicine for Lung Canceron October 11, 2021 at 1:45 pm
A new report could point the way toward improved precision therapy for patients with epidermal growth factor receptor (EGFR)-driven lung cancers. The study, published in the journal Advanced Science, ...
- Europe Epigenetics Market Size 2021 – Global Growth, Trends, Industry Analysis, Key Players and Forecast 2024on October 10, 2021 at 10:56 pm
Europe Epigenetics Market Report provides comprehensive market analysis and includes information, facts, historical ...
- Epigenetics, the misunderstood science that could shed new light on ageingon October 10, 2021 at 5:12 am
The study of epigenetics seems to reinforce the case that it’s not nature versus nurture, but nature plus nurture Even at the time, sceptics pointed out that it was fiendishly difficult to ...
- Epigenetics Market Size, Growth and Key Manufacturers – Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Radon October 8, 2021 at 3:07 pm
The Epigenetics Market is expected to surge at a steady CAGR in the coming years, states the latest Verified Market Research® report. The publication offers an insightful take on the historical data ...
- Epigenetics predicts the efficacy of T-lymphocyte treatments in hematological malignancieson October 4, 2021 at 8:04 am
Epigenetics predicts the efficacy of T-lymphocyte treatments in hematological malignancies by Josep Carreras Leukaemia Research Institute Credit: CC0 Public Domain ...
- Epigenetics answers questions about MSon October 1, 2021 at 5:25 pm
Maja Jagodic studies how the disease MS arises and why it affects people so differently. Research at an epigenetic level is appropriate both for understanding the disease and for finding new ways to ...
- Scientists can now tell if you had a ‘vanishing’ twin in the wombon October 1, 2021 at 3:06 am
Epigenetics is the study of how genes turn on or off depending on a person’s behaviors and environment. Geneticists know that fraternal twins run in families, which suggests something in our DNA ...
via Bing News